Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
about
Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activityX-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalizationContribution of caspase(s) to the cell cycle regulation at mitotic phaseDown-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repairOvercoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene × environment interactions.Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.Domain organization of XAF1 and the identification and characterization of XIAP(RING) -binding domain of XAF1.Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.Role of mTOR, Bad, and Survivin in RasGAP Fragment N-Mediated Cell ProtectionDiscovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors.Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk geneSurvivin and IAP proteins in cell-death mechanismsThe Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of SurvivinNondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradationEpigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex.Interferon-gamma enhances radiation-induced cell death via downregulation of Chk1.Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.Nucleotide composition of cellular internal ribosome entry sites defines dependence on NF45 and predicts a posttranscriptional mitotic regulonThe RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.IAPs: what's in a name?IAP-targeted therapies for cancer.Inhibitor of apoptosis proteins in hematological malignancies.XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosisXIAP as a ubiquitin ligase in cellular signaling.NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.Inhibitors of apoptotic proteins: new targets for anticancer therapy.Implication of 14-3-3ε and 14-3-3θ/τ in proteasome inhibition-induced apoptosis of glioma cells.The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.Liaisons between survivin and Plk1 during cell division and cell death.Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
P2860
Q24299156-45A50BD6-FB4A-455F-8D7E-883AE5F816D9Q24314543-D3523F17-B9C5-4FC5-9B6C-54A1D48D899AQ27348581-0229E73D-F2E9-467C-8B8D-EFA52CC531AEQ33491820-A5463A66-0B1D-4BCB-87ED-8E66D0F75024Q33709432-31308F7D-3537-43BD-A7D1-B676E7A1314EQ33841579-34D3BA23-03FC-4BFF-A0F3-622021C0516BQ33911252-396BF430-F08D-498A-B6B1-758F47D0D303Q33998969-6E7CC4A5-DD67-4160-8E38-EBBDDDCC241BQ34206206-ED79FA9C-ACAD-462A-A907-900740088047Q34221867-758941D7-451D-4C37-B9F7-F925AB7BAEA2Q34343401-A4A469D3-A5F9-4689-ACB8-2C1F84D7FE4BQ34420971-2DBC92C3-6258-46F7-BF5E-A9353CDDAAE2Q34797799-861E39B9-A114-47BA-B49E-8792ECB5843CQ35119355-3B2B7353-D5B2-41CA-B450-6555DBCFA002Q35129468-A97A5C5B-6660-4508-A527-EEA4270CD73AQ35414780-4645E0FB-CFD4-4FA4-B3BC-73D2F0EEBA29Q35583027-6A8064FB-926B-456D-A655-52DC948A41A3Q35770711-26EDAA65-CD94-43C6-AD7E-9D8F8B4769A4Q36129174-59F465C7-09F4-4C14-B918-46953C55502EQ36214738-5647B061-6C6B-40D1-BC48-1C0BCED1513AQ36289878-99CD2B00-1EC6-4543-A2AC-6230003E534AQ36423258-EA3E9716-A7F9-457F-AB69-2BB5179DD792Q36559689-5E407F79-58F7-4398-A8E0-36D69F93AB3DQ36739928-5BE0D6AB-4336-4630-913B-01550AC7A400Q37148694-312EEE27-A762-4C62-BC52-E0954BCE83F4Q37302745-3B23C778-01B4-4600-A18F-18128BAB5F0CQ37336610-9EDD923F-7397-46FF-AD9D-4C5D67C320CBQ37376242-2F656DB6-1B64-409F-B816-941AF5E2B918Q37546803-E63AEA7E-F2DB-4087-B7FA-4D48E9FF3782Q37615242-7B3CB5D7-8999-4590-B067-20694E1E327FQ37637565-323A163E-72F1-4047-A8FB-27DDDBD01BFDQ37702716-39534F63-EF7C-4584-BBED-D9AE2C075C9CQ37716498-B7F03E3A-17ED-4948-8742-7E46A3731336Q37875078-C46CA9D3-67D3-4901-B7D4-60A700E60A0DQ38116086-29F08224-B439-4D97-B387-A0E5FDF2D3FFQ39269737-93FA6F61-DD9F-4782-B4AE-3067F4922AEAQ39300041-BAE1B0BF-B208-4479-AA13-7DB2435390A7Q39523533-59BEE4A3-0575-4FCE-B6DF-FB3E56468823Q39709805-18AD131F-81D2-49E5-A3E5-CF3097292E61Q39788190-70BF0125-7E1A-4CDB-A207-62DF96A0BFF0
P2860
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
@ast
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
@en
Degradation of survivin by the X-linked inhibitor of apoptosis
@nl
type
label
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
@ast
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
@en
Degradation of survivin by the X-linked inhibitor of apoptosis
@nl
prefLabel
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
@ast
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
@en
Degradation of survivin by the X-linked inhibitor of apoptosis
@nl
P2093
P2860
P356
P1476
Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
@en
P2093
Herman H Cheung
O Cristina Micali
Peter Liston
Robert G Korneluk
Stéphanie Plenchette
Vinay Arora
P2860
P304
26202-26209
P356
10.1074/JBC.M700776200
P407
P577
2007-07-05T00:00:00Z